A cataract that has material basis in variation in the region 17p13.
Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation for cataract 24 is limited primarily due to its rarity and the absence of identified genetic variants. As this condition affects a small population, comprehensive clinical studies have not been conducted. The genetic basis remains unclear, which complicates the understanding of its pathophysiology and clinical management. Ongoing research may help to elucidate these gaps in knowledge.
The primary clinical feature of cataract 24 is the presence of anterior polar cataracts, which are observed in all affected individuals. These cataracts can significantly impair vision, often leading to amblyopia in a majority of cases (80-99%). The onset of cataract 24 typically occurs in infancy, necessitating early diagnosis and management to prevent long-term visual impairment.
To navigate cataract 24 effectively, consider consulting with an ophthalmologist who specializes in hereditary eye diseases. Genetic counseling may also be beneficial, even though no specific genetic basis has been identified yet. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials could be an option to consider, as they may provide access to cutting-edge research and treatments.
Currently, there is one active clinical trial investigating cataract 24. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to novel treatment approaches and contribute to the understanding of cataract 24. For more information on the active trial, you can visit ClinicalTrials.gov and search for 'cataract 24'.
Actionable guidance for navigating care for cataract 24
To navigate cataract 24 effectively, consider consulting with an ophthalmologist who specializes in hereditary eye diseases. Genetic counseling may also be beneficial, even though no specific genetic basis has been identified yet. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials could be an option to consider, as they may provide access to cutting-edge research and treatments.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for cataract 24 is limited primarily due to its rarity and the absence of identified genetic variants. As this condition affects a small population, comprehensive clinical studies have not been conducted. The genetic basis remains unclear, which complicates the understanding of its pathophysiology and clinical management. Ongoing research may help to elucidate these gaps in knowledge.
The primary clinical feature of cataract 24 is the presence of anterior polar cataracts, which are observed in all affected individuals. These cataracts can significantly impair vision, often leading to amblyopia in a majority of cases (80-99%). The onset of cataract 24 typically occurs in infancy, necessitating early diagnosis and management to prevent long-term visual impairment.
To navigate cataract 24 effectively, consider consulting with an ophthalmologist who specializes in hereditary eye diseases. Genetic counseling may also be beneficial, even though no specific genetic basis has been identified yet. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials could be an option to consider, as they may provide access to cutting-edge research and treatments.
Currently, there is one active clinical trial investigating cataract 24. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to novel treatment approaches and contribute to the understanding of cataract 24. For more information on the active trial, you can visit ClinicalTrials.gov and search for 'cataract 24'.
Actionable guidance for navigating care for cataract 24
To navigate cataract 24 effectively, consider consulting with an ophthalmologist who specializes in hereditary eye diseases. Genetic counseling may also be beneficial, even though no specific genetic basis has been identified yet. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials could be an option to consider, as they may provide access to cutting-edge research and treatments.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for cataract 24 is limited primarily due to its rarity and the absence of identified genetic variants. As this condition affects a small population, comprehensive clinical studies have not been conducted. The genetic basis remains unclear, which complicates the understanding of its pathophysiology and clinical management. Ongoing research may help to elucidate these gaps in knowledge.
The primary clinical feature of cataract 24 is the presence of anterior polar cataracts, which are observed in all affected individuals. These cataracts can significantly impair vision, often leading to amblyopia in a majority of cases (80-99%). The onset of cataract 24 typically occurs in infancy, necessitating early diagnosis and management to prevent long-term visual impairment.
To navigate cataract 24 effectively, consider consulting with an ophthalmologist who specializes in hereditary eye diseases. Genetic counseling may also be beneficial, even though no specific genetic basis has been identified yet. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials could be an option to consider, as they may provide access to cutting-edge research and treatments.
Currently, there is one active clinical trial investigating cataract 24. While there are no orphan drugs designated for this condition, participation in clinical trials may provide access to novel treatment approaches and contribute to the understanding of cataract 24. For more information on the active trial, you can visit ClinicalTrials.gov and search for 'cataract 24'.
Actionable guidance for navigating care for cataract 24
To navigate cataract 24 effectively, consider consulting with an ophthalmologist who specializes in hereditary eye diseases. Genetic counseling may also be beneficial, even though no specific genetic basis has been identified yet. You can find a genetic counselor through the National Society of Genetic Counselors at findageneticcounselor.com. Additionally, participating in clinical trials could be an option to consider, as they may provide access to cutting-edge research and treatments.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Age of onset indicates when symptoms typically first appear.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.